Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|May 21, 2020
From Environment to Genome and Back: A Lesson from HFE MutationsRaffaela Rametta, Marica Meroni, Paola DongiovanniInternational Journal of Molecular Sciences|December 6, 2018
Genetic and Epigenetic Modifiers of Alcoholic Liver DiseaseMarica Meroni, Miriam Longo, Raffaela Rametta, et al.Expert Review of Gastroenterology & Hepatology|December 8, 2015
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Paola Dongiovanni, Raffaela Rametta, Marica Meroni, et al.Current Pharmaceutical Design|February 1, 2020
Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?Raffaela Rametta, Anna L Fracanzani, Silvia Fargion, et al.World Journal of Hepatology|September 12, 2013
A novel alpha1-antitrypsin null variant (PiQ0Milano )Raffaela Rametta, Gabriella Nebbia, Paola Dongiovanni, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2004
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70Diego Albani, Erika Peverelli, Raffaela Rametta, et al.Plos One|April 3, 2008
DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70Sara Batelli, Diego Albani, Raffaela Rametta, et al.Diabetes|August 31, 2013
Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver diseaseLuca Valenti, Rosa M Mendoza, Raffaela Rametta, et al.The American Journal of Pathology|December 19, 2009
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesisPaola Dongiovanni, Anna Ludovica Fracanzani, Gaetano Cairo, et al.Journal of Hepatology|August 27, 2010
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseLuca Valenti, Elena Canavesi, Enrico Galmozzi, et al.Pageof 6